Merck completes acquisition of EyeBio Ruchika Sharma14 July 2024 10:00 AM ISTRahway: Merck, known as MSD outside of the United States and Canada, has announced the completion of the acquisition of Eyebiotech Limited...
Merck Animal Health concludes acquisition of Elanco Aqua business Ruchika Sharma12 July 2024 2:44 PM ISTRahway: Merck Animal Health, known as MSD Animal Health outside of the United States and Canada, a division of Merck & Co., Inc., Rahway,...
Merck discontinues Phase 3 trial of Xevinapant in locally advanced head and neck cancer Ruchika Sharma27 Jun 2024 5:04 PM ISTGermany: Merck, a science and technology company, has announced the discontinuation of the Phase III randomized TrilynX study evaluating...
Merck Capvaxive gets USFDA nod for prevention of Invasive Pneumococcal Disease, Pneumococcal Pneumonia in adults Ruchika Sharma18 Jun 2024 2:04 PM ISTRahway: Merck, known as MSD outside of the United States and Canada, has announced that the U.S. Food and Drug Administration (FDA) has approved...
USFDA approves Merck Keytruda plus Carboplatin, Paclitaxel for Primary Advanced or Recurrent Endometrial Carcinoma Ruchika Sharma18 Jun 2024 11:30 AM ISTRahway: Merck, known as MSD outside of the United States and Canada, has announced the U.S. Food and Drug Administration (FDA) has approved...
Focused on second- and third-generation opportunities in cardiometabolic drugs market: Merck Ruchika Sharma12 Jun 2024 1:46 PM ISTMerck emphasized its focus on second- and third-generation opportunities within the cardiometabolic drugs market, including weight-loss therapies, the...
USFDA grants priority review to Merck application for Keytruda plus chemotherapy for Metastatic Malignant Pleural Mesothelioma Ruchika Sharma1 Jun 2024 12:30 PM ISTRahway: Merck, known as MSD outside of the United States and Canada, has announced the U.S. Food and Drug Administration (FDA) has accepted for...
Merck unveils Software for Complete Data Traceability in Microbial QC Ruchika Sharma29 May 2024 3:05 PM ISTMerck, a science and technology company, has launched its M-Trace Software & Mobile App, a comprehensive data tracking solution to digitize...
Merck close to sealing USD 1.3 billion cash deal for Eyebiotech: Report Ruchika Sharma29 May 2024 10:15 AM ISTLondon: Merck & Co is close to finalizing a cash acquisition deal worth $1.3 billion for Eyebiotech, a biotechnology company specializing in...
MSD Animal Health gets European Commission marketing nod for INNOVAX-ND-H5 vaccine for chickens Ruchika Sharma28 May 2024 9:00 AM ISTRahway: MSD Animal Health, a division of Merck & Co., Inc., Rahway, N.J., USA, has announced that the European Commission has granted the...
Merck discontinues Vibostolimab, Pembrolizumab coformulation arm of Phase 3 KeyVibe-010 trial in Melanoma Ruchika Sharma14 May 2024 4:17 PM ISTRahway: Merck, known as MSD outside of the United States and Canada, has announced the discontinuation of the vibostolimab and pembrolizumab...
Phase 3 trial evaluating Keytruda in endometrial cancer misses primary survival endpoint: Merck Ruchika Sharma11 May 2024 12:41 PM ISTRahway: Merck, known as MSD outside of the United States and Canada, has announced that the Phase 3 KEYNOTE-B21 trial evaluating KEYTRUDA,...
